In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Oncolytics Biotech, Inc’s stock clocked out at $0.99, down -2.94% from its previous closing price of $1.02. In other words, the price has decreased by -$2.94 from its previous closing price. On the day, 0.54 million shares were traded. ONCY stock price reached its highest trading level at $1.04 during the session, while it also had its lowest trading level at $0.9502.
Ratios:
To gain a deeper understanding of ONCY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 06, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 95635984 and an Enterprise Value of 73631016.
Stock Price History:
The Beta on a monthly basis for ONCY is 1.09, which has changed by 0.020618558 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.53, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 25.55%, while the 200-Day Moving Average is calculated to be 24.93%.
Shares Statistics:
It appears that ONCY traded 1.15M shares on average per day over the past three months and 947610 shares per day over the past ten days. A total of 96.60M shares are outstanding, with a floating share count of 94.25M. Insiders hold about 2.43% of the company’s shares, while institutions hold 9.90% stake in the company. Shares short for ONCY as of 1752537600 were 2434204 with a Short Ratio of 2.12, compared to 1749772800 on 2605451. Therefore, it implies a Short% of Shares Outstanding of 2434204 and a Short% of Float of 2.6099999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Oncolytics Biotech, Inc (ONCY) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.31 and -$0.39 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.38, with 3.0 analysts recommending between -$0.33 and -$0.42.
